Inner Banner

Research Projects

Genetic and functional characterization of high risk acute promyelocytic leukemia


With the advent of targeted therapy using arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) very high cure rates (>90%) can be achieved in low/intermediate risk group APLs However, high risk group patients (white blood cell counts >10000/ul) still requires chemotherapy. The majority of post-remission deaths and relapses are linked to high risk group patients due to toxicity associated with chemotherapy or acquired ATO resistance. We plan to study the molecular & functional characteristics of high risk APL using patients’ samples, cell lines and orthotopic mouse models of APL.

Back to Top